Volume 393, Number 10176
16 March 2019
WORLD REPORT The announcement came as a surprise, prompting many to ask: Can the US FDA commissioner’s policies continue without him? Susan Jaffe reports.
Volume 393, Number 10176
16 March 2019
WORLD REPORT The announcement came as a surprise, prompting many to ask: Can the US FDA commissioner’s policies continue without him? Susan Jaffe reports.
Volume 393, Number 10175
9 March 2019
WORLD REPORT A committee brought together Senators and drug company representatives to discuss why drug pricing in the USA is so high, but little progress was made, Susan Jaffe reports.
Susan Jaffe | Washington Correspondent for The Lancet | 27th December 2017
…
Susan Jaffe | Washington Correspondent for The Lancet | 13th January 2016
No single federal agency reviews US drug prices, but 51 members of the U. S. House of Representatives have discovered a 35-year-old law that allows the government to control huge hikes in drug costs. And they want the Department of Health and Human Services and National Institutes of Health (HHS) to use it. Earlier this week the group led by Texas Democrat Lloyd Doggett wrote to HHS Secretary Sylvia Matthews Burwell and NIH director Dr. Francis Collins to explain why. [Continued here]…